993 related articles for article (PubMed ID: 26418168)
1. Total Saponin from Anemone flaccida Fr. Schmidt Prevents Bone Destruction in Experimental Rheumatoid Arthritis via Inhibiting Osteoclastogenesis.
Liu C; Yang Y; Sun D; Wang C; Wang H; Jia S; Liu L; Lin N
Rejuvenation Res; 2015 Dec; 18(6):528-42. PubMed ID: 26418168
[TBL] [Abstract][Full Text] [Related]
2. Fengshi Qutong capsule ameliorates bone destruction of experimental rheumatoid arthritis by inhibiting osteoclastogenesis.
Li Y; Yang C; Jia K; Wang J; Wang J; Ming R; Xu T; Su X; Jing Y; Miao Y; Liu C; Lin N
J Ethnopharmacol; 2022 Jan; 282():114602. PubMed ID: 34492323
[TBL] [Abstract][Full Text] [Related]
3. Boldine isolated from Litsea cubeba inhibits bone resorption by suppressing the osteoclast differentiation in collagen-induced arthritis.
Zhao H; Xu H; Qiao S; Lu C; Wang G; Liu M; Guo B; Tan Y; Ju D; Xiao C
Int Immunopharmacol; 2017 Oct; 51():114-123. PubMed ID: 28826044
[TBL] [Abstract][Full Text] [Related]
4. RANKL targeted peptides inhibit osteoclastogenesis and attenuate adjuvant induced arthritis by inhibiting NF-κB activation and down regulating inflammatory cytokines.
Naidu VG; Dinesh Babu KR; Thwin MM; Satish RL; Kumar PV; Gopalakrishnakone P
Chem Biol Interact; 2013 Apr; 203(2):467-79. PubMed ID: 23333834
[TBL] [Abstract][Full Text] [Related]
5. Total saponin from Anemone flaccida Fr. Schmidt abrogates osteoclast differentiation and bone resorption via the inhibition of RANKL-induced NF-κB, JNK and p38 MAPKs activation.
Kong X; Wu W; Yang Y; Wan H; Li X; Zhong M; Zhao H; Su X; Jia S; Ju D; Lin N
J Transl Med; 2015 Mar; 13():91. PubMed ID: 25889035
[TBL] [Abstract][Full Text] [Related]
6. IL-6 signal blockade ameliorates the enhanced osteoclastogenesis and the associated joint destruction in a novel FcγRIIB-deficient rheumatoid arthritis mouse model.
Ohtsuji M; Lin Q; Nishikawa K; Ohtsuji N; Okazaki H; Tsurui H; Amano H; Shirai T; Nishimoto N; Nishimura H; Hirose S
Mod Rheumatol; 2015 Mar; 25(2):270-7. PubMed ID: 25159156
[TBL] [Abstract][Full Text] [Related]
7. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
[TBL] [Abstract][Full Text] [Related]
8. TWEAK promotes osteoclastogenesis in rheumatoid arthritis.
Park JS; Kwok SK; Lim MA; Oh HJ; Kim EK; Jhun JY; Ju JH; Park KS; Park YW; Park SH; Kim HY; Cho YG; Cho ML
Am J Pathol; 2013 Sep; 183(3):857-67. PubMed ID: 23845567
[TBL] [Abstract][Full Text] [Related]
9. Osteoprotegerin reduces osteoclast numbers and prevents bone erosion in collagen-induced arthritis.
Romas E; Sims NA; Hards DK; Lindsay M; Quinn JW; Ryan PF; Dunstan CR; Martin TJ; Gillespie MT
Am J Pathol; 2002 Oct; 161(4):1419-27. PubMed ID: 12368214
[TBL] [Abstract][Full Text] [Related]
10. Asperosaponin VI protects against bone destructions in collagen induced arthritis by inhibiting osteoclastogenesis.
Liu K; Liu Y; Xu Y; Nandakumar KS; Tan H; He C; Dang W; Lin J; Zhou C
Phytomedicine; 2019 Oct; 63():153006. PubMed ID: 31299594
[TBL] [Abstract][Full Text] [Related]
11. The inhibitory effects of a RANKL-binding peptide on articular and periarticular bone loss in a murine model of collagen-induced arthritis: a bone histomorphometric study.
Kato G; Shimizu Y; Arai Y; Suzuki N; Sugamori Y; Maeda M; Takahashi M; Tamura Y; Wakabayashi N; Murali R; Ono T; Ohya K; Mise-Omata S; Aoki K
Arthritis Res Ther; 2015 Sep; 17(1):251. PubMed ID: 26373710
[TBL] [Abstract][Full Text] [Related]
12. Cytokine-controlled RANKL and osteoprotegerin expression by human and mouse synovial fibroblasts: fibroblast-mediated pathologic bone resorption.
Tunyogi-Csapo M; Kis-Toth K; Radacs M; Farkas B; Jacobs JJ; Finnegan A; Mikecz K; Glant TT
Arthritis Rheum; 2008 Aug; 58(8):2397-408. PubMed ID: 18668542
[TBL] [Abstract][Full Text] [Related]
13. Triptolide Prevents Bone Destruction in the Collagen-Induced Arthritis Model of Rheumatoid Arthritis by Targeting RANKL/RANK/OPG Signal Pathway.
Liu C; Zhang Y; Kong X; Zhu L; Pang J; Xu Y; Chen W; Zhan H; Lu A; Lin N
Evid Based Complement Alternat Med; 2013; 2013():626038. PubMed ID: 23573139
[TBL] [Abstract][Full Text] [Related]
14. The peroxisome proliferator-activated receptor γ agonist pioglitazone preserves bone microarchitecture in experimental arthritis by reducing the interleukin-17-dependent osteoclastogenic pathway.
Koufany M; Chappard D; Netter P; Bastien C; Weryha G; Jouzeau JY; Moulin D
Arthritis Rheum; 2013 Dec; 65(12):3084-95. PubMed ID: 23982996
[TBL] [Abstract][Full Text] [Related]
15. IL-1β and TNFα-initiated IL-6-STAT3 pathway is critical in mediating inflammatory cytokines and RANKL expression in inflammatory arthritis.
Mori T; Miyamoto T; Yoshida H; Asakawa M; Kawasumi M; Kobayashi T; Morioka H; Chiba K; Toyama Y; Yoshimura A
Int Immunol; 2011 Nov; 23(11):701-12. PubMed ID: 21937456
[TBL] [Abstract][Full Text] [Related]
16. RANKL inhibition by osteoprotegerin prevents bone loss without affecting local or systemic inflammation parameters in two rat arthritis models: comparison with anti-TNFalpha or anti-IL-1 therapies.
Stolina M; Schett G; Dwyer D; Vonderfecht S; Middleton S; Duryea D; Pacheco E; Van G; Bolon B; Feige U; Zack D; Kostenuik P
Arthritis Res Ther; 2009; 11(6):R187. PubMed ID: 20003323
[TBL] [Abstract][Full Text] [Related]
17. Prolactin blocks the expression of receptor activator of nuclear factor κB ligand and reduces osteoclastogenesis and bone loss in murine inflammatory arthritis.
Ledesma-Colunga MG; Adán N; Ortiz G; Solís-Gutiérrez M; López-Barrera F; Martínez de la Escalera G; Clapp C
Arthritis Res Ther; 2017 May; 19(1):93. PubMed ID: 28506283
[TBL] [Abstract][Full Text] [Related]
18. Carnosic acid inhibits inflammation response and joint destruction on osteoclasts, fibroblast-like synoviocytes, and collagen-induced arthritis rats.
Liu M; Zhou X; Zhou L; Liu Z; Yuan J; Cheng J; Zhao J; Wu L; Li H; Qiu H; Xu J
J Cell Physiol; 2018 Aug; 233(8):6291-6303. PubMed ID: 29521424
[TBL] [Abstract][Full Text] [Related]
19. Protective effect of vasoactive intestinal peptide on bone destruction in the collagen-induced arthritis model of rheumatoid arthritis.
Juarranz Y; Abad C; Martinez C; Arranz A; Gutierrez-Cañas I; Rosignoli F; Gomariz RP; Leceta J
Arthritis Res Ther; 2005; 7(5):R1034-45. PubMed ID: 16207319
[TBL] [Abstract][Full Text] [Related]
20. A combination of sinomenine and methotrexate reduces joint damage of collagen induced arthritis in rats by modulating osteoclast-related cytokines.
Sun Y; Yao Y; Ding CZ
Int Immunopharmacol; 2014 Jan; 18(1):135-41. PubMed ID: 24287449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
